Concert Pharmaceuticals Inc Banner Image

Concert Pharmaceuticals Inc

  • Ticker CNCE
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Concert Pharmaceuticals Inc Logo Image
  • 51-200 Employees
  • Based in Lexington, Massachusetts
Concert Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule drugs for central nervous system disorders, genetic diseases, renal disease, inflammatory disease, and cancer. The company’s clinical-stage product candidates include AVP-786, which is in Phase II clinical trial for the treatment of neurologic and psychiatric disorders, includingMore pain, behavioral disorders, mood disorders, and movement disorders; CTP-499 that is in Phase II clinical trial for chronic kidney disease in patients with type 2 diabetes; and CTP-354, which is in Phase I clinical trial to spasticity associated with spinal cord injury and multiple sclerosis.
4.8 / 5.0 (174)

Concert Pharmaceuticals Inc reports have an aggregate usefulness score of 4.8 based on 174 reviews.

Concert Pharmaceuticals Inc

Most Recent Annual Report

Concert Pharmaceuticals Inc
MOST RECENT 2021 Annual Report and Form 10K

Concert Pharmaceuticals Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

Concert Pharmaceuticals Inc Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!